Ireland-based C2 Pharma has announced the receipt of approval for a C-DMF (drug master file) concerning its pilocarbine nitrate API. This critical active pharmaceutical ingredient (API), produced in collaboration with C2’s Brazilian partner, Anidro do Brasil, plays a vital role in the formulation of ophthalmic medications.
Key Features of Pilocarpine Nitrate
Pilocarpine nitrate, derived from the Jaborandi plant indigenous to Brazil, is primarily utilized in the treatment of glaucoma. Its application extends to various specific diagnostic purposes, underscoring its significance in the pharmaceutical landscape.
Strategic Partnerships Enhance Production
C2 Pharma’s partnership with Anidro do Brasil enhances the production capabilities of pilocarpine nitrate, ensuring a reliable supply for the growing demand in ophthalmic treatments. This collaboration not only strengthens C2 Pharma’s market position but also contributes to advancements in eye care therapies.- Flcube.com
